Hoyer P F, Krohn H P, Offner G, Byrd D J, Brodehl J, Wonigeit K, Pichlmayr R
Transplantation. 1987 Apr;43(4):489-93. doi: 10.1097/00007890-198704000-00006.
Clearance studies were performed in 32 transplanted children treated with CsA in combination with low-dose prednisolone (CsA group), and the results were compared with those of 29 children transplanted earlier and treated with azathioprine and prednisolone (CIS group). Serum creatinine and urea levels 6 weeks and 1 year after transplantation (Tx) were significantly higher in the CsA than in the CIS group. Clearance studies 6 weeks after Tx exhibited significantly lower rates in the CsA group: Cin = 47 +/- 16.5 versus 83 +/- 25 ml/min/1.73 sqm, CPAH = 271 +/- 110 versus 503 +/- 181 ml/min/1.73 sqm (P less than 0.001). The filtration fractions were not different (19.1 versus 17.1%). The tubular phosphate reabsorption per ml GFR (Tp/Cin) was only slightly lower in the CsA group (0.76 +/- 0.23 mumol/ml versus 0.93 +/- 0.29; P = 0.09). The endogenous glucose clearance rates were equally elevated in both groups and returned to normal after 1 year. The creatinine clearance (Ccr) had dropped in both groups by a mean for 13 ml/min/1.73 sqm between 6 weeks and 1 year after Tx. No correlation was found between the Ccr and the CsA blood levels, but Ccr was inversely correlated with the number of rejection episodes (r = -0.72, P = 0.001). In conclusion, renal allografts in CsA-treated children exhibited a significantly lower function than in CIS-treated children. The effect was related to the global kidney function without any signs of additional tubular toxicity and was apparent within the first weeks after Tx. Thereafter, the decline in graft function was comparable in both groups and could not be related to CsA treatment.
对32例接受环孢素A(CsA)联合小剂量泼尼松龙治疗的移植儿童进行了清除率研究(CsA组),并将结果与29例早期接受移植且用硫唑嘌呤和泼尼松龙治疗的儿童(CIS组)进行比较。移植(Tx)后6周和1年时,CsA组的血清肌酐和尿素水平显著高于CIS组。Tx后6周的清除率研究显示,CsA组的清除率显著较低:内生肌酐清除率(Cin)=47±16.5对83±25ml/min/1.73m²,对氨基马尿酸清除率(CPAH)=271±110对503±181ml/min/1.73m²(P<0.001)。滤过分数无差异(19.1%对17.1%)。CsA组每毫升肾小球滤过率(GFR)的肾小管磷重吸收率(Tp/Cin)仅略低(0.76±0.23μmol/ml对0.93±0.29;P=0.09)。两组的内生葡萄糖清除率均同样升高,并在1年后恢复正常。Tx后6周和1年之间,两组的肌酐清除率(Ccr)平均下降了13ml/min/1.73m²。未发现Ccr与CsA血药浓度之间存在相关性,但Ccr与排斥反应次数呈负相关(r=-0.72,P=0.001)。总之,接受CsA治疗的儿童肾移植受者的肾功能显著低于接受CIS治疗的儿童。这种影响与整体肾功能有关,无任何额外肾小管毒性的迹象,且在Tx后的最初几周内就很明显。此后,两组移植肾功能的下降情况相当,且与CsA治疗无关。